Azelastine hydrochloride inhibits platelet activating factor-like activity in human eosinophils-Reference-Cited by-同舟云学术

Azelastine hydrochloride inhibits platelet activating factor-like activity in human eosinophils

Published:1996-10 Issue:4 Volume:55 Page:217-221
ISSN:0952-3278
Container-title:Prostaglandins, Leukotrienes and Essential Fatty Acids
language:en
Short-container-title:Prostaglandins, Leukotrienes and Essential Fatty Acids

Author:

Shindo Kunihiko,Fukumura Motonori

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry

Reference22 articles.

1. Pharmacological and toxicological properties of azelastine, a novel antiallergic agent;Zechel;Arzneimittelforschung,1981

2. Inhibition of leukotriene(SRS-A)-mediated allergic bronchospasm by azelastine, a novel, orally effective antiasthmatic drug;Chand;J Allergy Clin Immunol,1983

3. Antiallergic effect of azelastine hydrochloride on immediate type hypersensitivity reactions in vivo and in vitro;Katayama;Arzneimittelforschung,1981

4. Inhibition by azelastine of non-allergic histamine release from rat peritoneal mast cells;Fields;J Allergy Clin Immunol,1984

5. Inhibition of allergic histamine release by azelastine and selected antiallergic drugs from rabbit leukocytes;Chand;Int Arch Allergy Appl Immunol,1985

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiallergic drugs, azelastine hydrochloride and epinastine hydrochloride, inhibit ongoing IgE secretion of rat IgE-producing hybridoma FE-3 cells;European Journal of Pharmacology;2006-10

2. Preclinical evidence of azelastine hydrochloride activity;Current Therapeutic Research;2002-09

3. New Insights into the Second Generation Antihistamines;Drugs;2001

4. Oxatomide inhibits synthesis and release of platelet-activating factor in human neutrophils;Prostaglandins, Leukotrienes and Essential Fatty Acids;1998-02

5. Inhibitory effect of azelastine hydrochloride on synthesis and release of platelet activating factor from human alveolar macrophages;Prostaglandins, Leukotrienes and Essential Fatty Acids;1997-12